Regulation - Pricing, Jakavi

Filter

Current filters:

PricingJakavi

Popular Filters

Setback for myelofibrosis patients as UK's NICE rejects Novartis' Jakavi

26-06-2013

Swiss drug major Novartis today (June 26) expressed disappointment at the decision of UK drugs watch…

EuropeJakaviNovartisOncologyPharmaceuticalPricingRegulation

UK's NICE says no to Novartis' Jakavi for enlarged spleen

26-04-2013

UK drugs watchdog the National Institute for Health and Care Excellence (NICE) has published final draft…

EuropeJakaviNovartisPharmaceuticalPricingRegulation

UK's NICE says no to Novartis' Jakavi for myelofibrosis in draft guidance

13-02-2013

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has today (February…

EuropeJakaviNovartisOncologyPharmaceuticalPricingRegulation

Back to top